血清生长分化因子15和甲胎蛋白联合检测对HBV相关肝细胞癌的诊断价值

李欢; 陈娟娟; 祝成亮; 张平安

doi:10.3969/j.issn.1001-5256.2020.03.020

血清生长分化因子15和甲胎蛋白联合检测对HBV相关肝细胞癌的诊断价值

DOI: 10.3969/j.issn.1001-5256.2020.03.020

武汉大学人民医院检验科

基金项目:

国家自然科学基金(81672079)；

详细信息

中图分类号: R735.7;R512.62
计量
- 文章访问数: 944
- HTML全文浏览量: 17
- PDF下载量: 205
- 被引次数: 0
出版历程
- 收稿日期: 2019-10-19
- 出版日期: 2020-03-20

Value of combined measurement of serum growth differentiation factor 15 and alpha-fetoprotein in the diagnosis of hepatitis B virus-related hepatocellular carcinoma

Department of Clinical Laboratory,Renmin Hospital of Wuhan University

Research funding:

摘要

摘要: 目的探讨血清生长分化因子15（GDF15）和AFP联合检测对诊断HBV感染相关肝细胞癌（HCC）的临床价值。方法选取2019年3月1日-2019年9月1日在武汉大学人民医院诊治的患者和健康体检者共225例,其中HBV感染导致的HCC患者（HCC组） 97例,慢性乙型肝炎患者（CHB组） 41例,健康体检者（NC组） 87例,分别测定三组人群的GDF15和AFP水平。计量资料采用单样本Kolmogorov-Smirnov法检验各组数据是否符合正态性,正态分布资料多组间比较采用方差分析,进一步两两比较采用LSD-t检验;非正态分布资料多组间比较采用Kruskal-Wallis H检验,两两比较采用Mann-Whitney U检验。计数资料采用χ2检验。采用二元logistic回归分析得到GDF15和AFP联合的回归模型,并绘制GDF15和AFP单独或联合检测的ROC曲线,计算曲线下面积及灵敏度、特异度和约登指数。结果 HCC组、CHB组和NC组的GDF15和AFP水平差异均有统计学意义（χ2值分别为53. 77、119. 12,P值均<0....
- 癌,肝细胞 /
- 生长分化因子 /
- 甲胎蛋白类
Abstract: Objective To investigate the clinical value of combined measurement of serum growth differentiation factor 15( GDF15) and alpha-fetoprotein( AFP) in the diagnosis of hepatocellular carcinoma( HCC) associated with hepatitis B virus( HBV) infection. Methods A total of 225 subjects who received treatment or underwent physical examination in Renmin Hospital of Wuhan University from March 1 to September 1,2019,were enrolled,among whom there were 97 patients with HCC caused by HBV infection( HCC group),41 patients with chronic hepatitis B( CHB group),and 87 healthy individuals( NC group),and the levels of GDF15 and AFP were measured for all three groups. The one-sample Kolmogorov-Smirnov test was used to determine whether the data were normally distributed or not; an analysis of variance was used for comparison of normally distributed data between multiple groups,and the least significant difference t-test was used for further comparison between two groups; the Kruskal-Wallis H test was used for comparison of non-normally distributed data between multiple groups,and the Mann-Whitney U test was used for further comparison between two groups. The chi-square test was used for comparison of categorical data. A binary logistic regression analysis was used to obtain the regression model of GDF15 and AFP; the receiver operating characteristic( ROC) curve was plotted for GDF15 and AFP used alone or in combination,and the area under the ROC curve( AUC),sensitivity,specificity,and Youden index were calculated. Results There were significant differences in the levels of GDF15 and AFP between the HCC group,the CHB group,and the NC group( χ2= 53. 77 and 119. 12,both P < 0. 01); the HCC group had a significantly higher level of GDF15 than the CHB group and the NC group( both P < 0. 01),the HCC group and the CHB group had a significantly higher level of AFP than the NC group,and the HCC group had a significantly higher level of AFP than the CHB group( all P < 0. 01). The ROC curve analysis showed that GDF15 alone had an AUC of 0. 752,a sensitivity of 74. 0%,and a specificity of 68. 3%,AFP alone had an AUC of 0. 660,a sensitivity of 45. 8%,and a specificity of 85. 4%,and GDF15 combined with AFP had an AUC of 0. 816,a sensitivity of 88. 4%,and a specificity of 68. 5%. Conclusion Combined measurement of GDF15 and AFP can improve the diagnostic efficiency for HBV-related HCC and has a high clinical value.
- carcinoma,hepatocellular /
- growth differentiation factors /
- alpha-fetoproteins

HTML全文

参考文献(17)

[1] KIM HS,El-SERAG HB. The epidemiology of hepatocellular carcinoma in the USA[J]. Curr Gastroenterol Rep,2019,21(4):17.

[2] MEIER JC,HAENDLER B,SEIDEL H,et al. Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis[J]. Cancer Med,2015,4(2):253-267.

[3] LEE ES,KIM SH,KIM HJ,et al. Growth differentiation factor15 predicts chronic liver disease severity[J]. Gut Liver,2017,11(2):276-282.

[4] National Health and Family Planning Commission of the People's Republic of China. Diagnosis,management,and treatment of hepatocellular carcinoma(V2017)[J]. J Clin Hepatol,2017,33(8):1419-1431.(in Chinese)中华人民共和国国家卫生和计划生育委员会．原发性肝癌诊疗规范(2017年版)[J]．临床肝胆病杂志，2017,33(8):1419-1431.

[5] CAO GL,HU XY,GENG WM,et al. Application of multiple serum tumor markers on the diagnosis of early primary liver cancer[J/CD]. Chin J Liver Dis(Electronic Version),2018,10(4):12-16.(in Chinese)曹国磊，胡小云，耿伟明，等．血清肿瘤标志物联合检测在早期原发性肝癌诊断的应用[J/CD]．中国肝脏病杂志(电子版)，2018,10(4):12-16.

[6] GUAN GW,YAO MJ,QIAN XJ,et al. Value of combined measurement of alpha-fetoprotein and alpha-fetoprotein L3%in the diagnosis of hepatocellular carcinom[J]. J Clin Hepatol,2019,35(7):1514-1519.(in Chinese)关贵文，姚明解，钱相君，等．AFP和AFP-L3%联合检测在肝细胞癌诊断中的应用价值[J]．临床肝胆病杂志，2019,35(7):1514-1519.

[7] XI LT,ZHANG HX,WU AR,et al. Value of combined measurement of serum alpha-fetoprotein,Dickkopf-1,and cytoskeleton-associated protein 4 in diagnosis of hepatocellular carcinoma[J]. J Clin Hepatol,2019,35(6):1276-1279.(in Chinese)奚黎婷，张慧娴，吴爱荣，等．血清甲胎蛋白、Dickkopf相关蛋白1、细胞骨架蛋白4联合检测对肝细胞癌的诊断价值[J]．临床肝胆病杂志，2019,35(6):1276-1279.

[8] XIE F,YU YC,XUE Z,et al. Screening strategy for primary hepatocellular carcinoma based on different combinations of protein induced by vitamin K absence or antagonist-Ⅱ，alpha-fetoprotein,and alpha-fetoprotein-L3[J]. J Clin Hepatol,2019,35(9):1975-1979.(in Chinese)谢芳，于乐成，薛珠，等．基于PIVKA-Ⅱ、AFP和AFP-L3不同组合模式的肝细胞癌筛查策略探讨[J]．临床肝胆病杂志，2019,35(9):1975-1979.

[9] WALLIN U,GLIMELIUS B,JIRSTROM K,et al. Growth differentiation factor 15:A prognostic marker for recurrence in colorectal cancer[J]. Br J Cancer,2011,104(10):1619-1627.

[10] LEE DH,YANG Y,LEE SJ,et al. Macrophage inhibitory cytokine-1 induces the invasiveness of gastric cancer cells by up-regulating the urokinase-type plasminogen activator system[J]. Cancer Res,2003,63(15):4648-4655.

[11] ALBERTONI M,SHAW PH,NOZAKI M,et al. Anoxia induces macrophage inhibitory cytokine-1(MIC-1)in glioblastoma cells independently of p53 and HIF-1[J]. Oncogene,2002,21(27):4212-4219.

[12] BAEK SJ,KIM KS,NIXON JB,et al. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities[J].Mol Pharmacol,2001,59(4):901-908.

[13] ZHANG L,YANG X,PAN HY,et al. Expression of growth differentiation factor 15 is positively correlated with histopathological malignant grade and in vitro cell proliferation in oral squamous cell carcinoma[J]. Oral Oncol,2009,45(7):627-632.

[14] WANG L,LIU Y,LI W,et al. Growth differentiation factor 15promotes cell viability,invasion,migration,and angiogenesis in human liver carcinoma cell line HepG2[J]. Clin Res Hepatol Gastroenterol,2017,41(4):408-414.

[15] LIU X,CHI X,GONG Q,et al. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma[J]. PLo S One,2015,10(5):e127518.

[16] CHEN GG,HO RL,WONG J,et al. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein(AFP)gene and its significance in hepatocellular carcinoma(HCC)[J]. Eur J Surg Oncol,2007,33(7):882-886.

[17] ZHU HJ,GU YF. Significance of combined detection of AFP,CA199,CA50 and ferr in the diagnosis of primary liver cancer[J/CD]. Chin J Clin Lab Sci(Electronic Edition),2019,8(4):268-269.(in Chinese)朱慧婧，顾益凤．血清中AFP、CA199、CA50和Ferr联合检测在原发性肝癌诊断中的意义[J/CD]．临床检验杂志(电子版)，2019,8(4):268-269.

施引文献

资源附件(0)

访问统计